scholarly journals Cognitive Bias Modification for Interpretation in Major Depression

2015 ◽  
Vol 3 (1) ◽  
pp. 126-139 ◽  
Author(s):  
Jutta Joormann ◽  
Christian E. Waugh ◽  
Ian H. Gotlib

Interpreting ambiguous stimuli in a negative manner is a core bias associated with depression. Investigators have used cognitive bias modification for interpretation (CBM-I) to demonstrate that it is possible to experimentally induce and modify these biases. In this study, we extend previous research by examining whether CBM-I affects not only interpretation but also memory and physiological stress response in individuals diagnosed with major depressive disorder. We found that CBM-I was effective in inducing an interpretive bias. Participants also exhibited memory biases that corresponded to their training condition and demonstrated differential physiological responding in a stress task. These results suggest that interpretation biases in depression can be modified and that this training can lead to corresponding changes in memory and to decreases in stress reactivity. Findings from this study highlight the importance of examining the relations among different cognitive biases in major depressive disorder and the possibility of modifying cognitive biases.

2017 ◽  
Vol 20 ◽  
Author(s):  
Simon E. Blackwell ◽  
Marcella L. Woud ◽  
Colin MacLeod

AbstractWhile control conditions are vitally important in research, selecting the optimal control condition can be challenging. Problems are likely to arise when the choice of control condition is not tightly guided by the specific question that a given study aims to address. Such problems have become increasingly apparent in experimental psychopathology research investigating the experimental modification of cognitive biases, particularly as the focus of this research has shifted from theoretical questions concerning mechanistic aspects of the association between cognitive bias and emotional vulnerability, to questions that instead concern the clinical efficacy of ‘cognitive bias modification’ (CBM) procedures. We discuss the kinds of control conditions that have typically been employed in CBM research, illustrating how difficulties can arise when changes in the types of research questions asked are not accompanied by changes in the control conditions employed. Crucially, claims made on the basis of comparing active and control conditions within CBM studies should be restricted to those conclusions allowed by the specific control condition employed. CBM studies aiming to establish clinical utility are likely to require quite different control conditions from CBM studies aiming to illuminate mechanisms. Further, conclusions concerning the clinical utility of CBM interventions cannot necessarily be drawn from studies in which the control condition has been chosen to answer questions concerning mechanisms. Appreciating the need to appropriately alter control conditions in the transition from basic mechanisms-focussed investigations to applied clinical research could greatly facilitate the translational process.


2020 ◽  
Author(s):  
Roos Wolbers ◽  
Christina Bode ◽  
Ester Siemerink ◽  
Sabine Siesling ◽  
Marcel Pieterse

BACKGROUND More than 50% of all breast cancer patients experience fatigue symptoms during and after their treatment course. Recent evidence shows that fatigue is partly driven by cognitive biases, such as the self-as-fatigued identity bias, which may be corrected with computer-based Cognitive Bias Modification (CBM) techniques. OBJECTIVE The aim of the current study was to design such a CBM-training by adopting a co-creation approach. METHODS Semi-structured interviews were conducted with seven health professionals, three breast cancer patients and two patient advocates. Aim of the interviews was to collect input for the design of the CBM-training, taking the values and preferences of the stakeholders into account and to determine the timing and implementation of the training in the treatment course. RESULTS Overall, the interviews showed that the concept of CBM was accepted among all stakeholders. Important requirements were revealed, such as that the training needs to be simple, undemanding, yet engaging and persuasive. Based on the results, eHealth app IVY (Implicit VitalitY) was created. Interviews suggested that IVY should be offered early in the treatment course and should be carefully aligned with clinical treatment. CONCLUSIONS Using CBM to target cancer-related fatigue in a preventive approach is an innovative technique, which is embraced by breast cancer stakeholders. The current study suggests CBM has several benefits, such as being easy to use, and potentially increasing perceived self-control in patients. CLINICALTRIAL


Author(s):  
Zhang Melvyn ◽  
Aloysius Chow ◽  
Ranganath Vallabhajosyula ◽  
Daniel SS Fung

Whilst cognitive bias modification was initially used in the treatment of anxiety disorders, it is also currently being used for the treatment of other psychopathologies. In fact, cognitive bias modification has been especially well-investigated amongst children and adolescents. A recent review suggests some evidence for the modification of interpretative biases amongst children with neurodevelopment disorders. There have since been other studies reporting of the existence of other cognitive biases, such as emotional biases, amongst individuals with attention deficit hyperactivity disorder (ADHD). This perspective article will discuss the epidemiology of ADHD and the nature of emotional biases that are present amongst individuals with ADHD. This perspective article also reviewed some of the studies that have assessed and modified emotional biases in individuals with ADHD. A total of three studies have been identified from the published literature that provide evidence for targeting emotional biases amongst individuals with ADHD. These studies provide us with preliminary evidence for the effectiveness of modifying emotional biases and how it could help in ameliorating symptoms related to emotional dysregulation. There needs to be future research in this area with further evidence supporting the effectiveness of modifying emotional biases. It is also crucial for future research to determine which of these tools is best at detecting such biases, and which of these tools are versatile enough and non-invasive that they could safely be implemented for both research and clinical needs.


Author(s):  
Melvyn W. B. Zhang ◽  
Helen E. Smith

In recent years, advances in experimental psychology have led to a better understanding in automatic, unconscious processes, referred to as attentional and approach biases amongst individuals with substance use disorders. Attentional biases refer to the relatively automatic tendencies for attention to be preferentially allocated towards substance-related cues. Whereas, approach bias refers to the relatively automatic behavioral tendencies of individuals to reach out to substance-related cues in their natural environment. While, several reviews confirm the existence of these biases, and the effectiveness of bias modification, the conduct of cognitive bias modification amongst substance-using individuals is not without its challenges. One of these is that cognitive biases, both attentional and approach biases, are not universally present; and several individual differences factors modulate the magnitude of the biases. Another challenge that investigators faced in their conduct of cognitive bias modification relates to the selection of the appropriate task for bias assessment and modification. Other challenges intrinsic to cognitive bias modification intervention relates to that of participant attrition, much like conventional psychotherapies. Negative findings, of the absence of biases at baseline, or the lack of effectiveness of bias modification have been reported in studies of cognitive bias modification. All these challenges could have an impact on bias assessment and modification. In this perspective paper, we will explore the literature surrounding each of these challenges and discuss potential measures that could be undertaken to mitigate these clinical and research challenges.


2020 ◽  
Vol 37 (5) ◽  
pp. 438-448
Author(s):  
Michelle Rozenman ◽  
Araceli Gonzalez ◽  
Christina Logan ◽  
Pauline Goger

2018 ◽  
Author(s):  
Melvyn Zhang ◽  
Jiangbo Ying ◽  
Guo Song ◽  
Daniel SS Fung ◽  
Helen Smith

UNSTRUCTURED Background: Traditional psychological therapies focus mainly on modification of individuals’ conscious decision-making process. Unconscious processes such as cognitive biases have been found to be accountable for various psychiatric psychopathologies. The advances in technologies have transformed how bias modification programs are being delivered. Objective: We seek to synthesize the current evidence of web-based cognitive bias modification for psychiatric disorders, by identifying the range of conditions targeted and their current efficacy. We wish to determine if web-based attention bias modification is as efficacious as compared to conventional methods. Methods and analysis: A systematic review will be conducted, and all studies types will be included. There will not be any restrictions on the participants included in the study. A search will be conducted on the respective databases up till 2017. Selection of studies will be by the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA-P) guidelines. Quality assessment of the included studies will be assessed using the Cochrane Risk of Bias tool (for randomized trials) and the Newcastle-Ottawa scale for other study designs. A narrative synthesises of the identified articles will be conducted. A meta-analysis will be considered, only if there are sufficient articles in a domain for statistical analysis. Ethical approval for the current protocol and the planned systematic review was not required. Results: Results synthesized would be disseminated using conference presentation or published works in peer-reviewed journals. Conclusions: This review is of importance given how technology transformed the delivery of conventional therapies. The findings from this review will provide guidance for future research involving technology and cognitive bias modification interventions. Registration details: International Prospective Register for Systematic Reviews (PROSPERO) number 2017 CRD42017074754


2018 ◽  
Author(s):  
Anne-Wil Kruijt ◽  
Per Carlbring

Cognitive Bias Modification (CBM) refers to various computerized training protocols aimed at modifying individuals’ automatic information processing patterns (cognitive biases). CBM protocols are commonly regarded as potential new treatments, targeting cognitive biases believed to be involved in, amongst others, anxiety, depression, substance abuse, disordered eating, pain perception, and insomnia. Designed to reward response tendencies associated with more desired information processing patterns trough repeated practice, CBM tasks tend to rely on a (hidden) contingency between stimulus valence and response rewards. In CBM studies, active training conditions are typically contrasted with control conditions lacking the contingency, often called 50/50 placebo. This report focusses on the wide-spread, and intuitive, notion that pre-existing bias may affect the contingency experienced by an individual engaging in a 50/50 placebo control condition thereby inadvertently rendering the intended placebo condition more potent. Employing probabilistic reasoning we conclude that, contrary to the often-forwarded notion, pre-existing bias cannot increase the potency of a 50/50 placebo condition. In contrast, we arrived at the unforeseen conclusion that lack of pre-existing bias may render an active training condition functionally similar to a placebo condition. In this paper we develop these arguments, review literature with respect to our assumptions, and discuss implications.


2018 ◽  
Author(s):  
Angela S Attwood ◽  
Tim M Williams ◽  
F. Joseph McClernon ◽  
Rachel Kozink ◽  
Sally Adams ◽  
...  

Drug-related cognitive biases have been positively associated with drug-craving and increased likelihood of relapse. Cognitive bias modification paradigms have been developed to attenuate cognitive biases but there have been few studies that examined neural responses to these paradigms. This study compared neural responses following CBM and explored whether CBM effects were potentiated by varenicline administration. This was a double-blind placebo-controlled study with two between subject factors of drug (varenicline, placebo) and CBM (attend towards smoking cues, train away from smoking cues, control training) that recruited daily (> 10 cigarettes per day) non-treatment seeking smokers. Participants (n = 67, 53% female) were randomised to one-week of drug administration (varenicline or placebo) before attending a study session at which they were randomised to CBM condition, and underwent an fMRI scan were they were presented with smoking and neutral cues. Neural response to smoking (vs. neutral) cues, cognitive bias, craving and mood were assessed. There was no evidence of CBM effects on any outcomes. There was evidence of effects of varenicline on craving, with greater reductions in craving in the week preceding the study session in the varencline group (p = 0.04, ηp2 = .06). There was also evidence of a drug by CBM interaction for neural responses (z = 3.78, p <0.001). Compared to placebo, varenicline was associated with greater activation in the right temporal middle gyrus in the CBM control condition, compared to an opposite effect in the CBM attend towards condition. These data suggest that CBM does not modify cognitive bias, subjective craving and mood, or neural response to smoking cues. There was also no evidence that CBM effects were potentiated by varenicline. Clinical trial registration ID #ISRCTN65690030


Sign in / Sign up

Export Citation Format

Share Document